cGMP-Aligned · FDA-Registered U.S. Facility · Third-Party COA on Every LotSupplied for Research Use Only
BioRegenEx · Research

Exosomes and the Immune System: How MSC Exosomes Modulate Inflammation | BioRegenEx

← Back to Research Library

One of the most active areas of MSC exosome research is immunomodulation — the ability to influence how immune cells behave and how inflammation resolves. This overview is educational only and does not describe a treatment.

Why exosomes reach immune cells

Exosomes are nanoscale vesicles (roughly 30–150 nm) that carry proteins, lipids, and nucleic acids such as microRNA. Because they are cell-free and small, they circulate readily and can interact with immune cells throughout the body. Researchers study MSC-derived exosomes as carriers of many of the same signaling molecules that their parent stem cells use to communicate with the immune system.

Macrophage polarization

A central theme in the literature is the effect on macrophages — immune cells that can adopt a pro-inflammatory (often called M1) or a pro-resolving, tissue-supportive (often called M2) state. Research suggests MSC exosomes can shift macrophage behavior toward the pro-resolving state, which is associated with reduced inflammatory signaling and a more repair-oriented environment.

T cells and regulatory balance

MSC exosomes are also studied for effects on T lymphocytes, including the promotion of regulatory T cells (Tregs) that help restrain excessive immune activity. In laboratory and preclinical models, this is examined in the context of autoimmune and inflammatory conditions, where an overactive immune response drives tissue damage.

Cytokine signaling

Much of the immune effect is described in terms of cytokines — the messenger proteins immune cells use. Studies frequently report shifts away from pro-inflammatory cytokines (such as TNF-α and certain interleukins) and toward anti-inflammatory signaling. The microRNA cargo carried inside exosomes is one proposed mechanism for these changes, since microRNAs can fine-tune which genes a recipient cell expresses.

Why source and characterization matter

The immune-related properties researchers describe depend heavily on the cells the exosomes came from, how they were manufactured, and how carefully they were characterized. Two preparations labeled “exosomes” can differ substantially in cargo and purity. This is why particle characterization, sterility testing, and a Certificate of Analysis matter so much when sourcing research-grade material.

Important information

This article is provided for educational and informational purposes only and does not constitute medical advice. Exosomes are not FDA-approved to diagnose, treat, cure, or prevent any disease. BioRegenEx supplies research-grade MSC exosomes for research use only, exclusively to licensed physicians and research institutions.

Important Information

These statements have not been evaluated by the U.S. Food and Drug Administration. BioRegenEx products are not intended to diagnose, treat, cure, or prevent any disease.

Exosome therapy is an emerging regenerative approach. It is investigational, outcomes vary, and individual results cannot be guaranteed. Patient testimonials reflect individual experiences and are not representative of typical results.

References to regulatory standards — including Section 351(a) of the Public Health Service Act — describe the company’s stated quality and compliance approach and should not be interpreted as FDA approval or endorsement of any product.

This presentation is provided for educational and informational purposes only and does not constitute medical advice. Treatment decisions should always be made in consultation with a qualified, licensed healthcare provider.